Today: 29 June 2026
National Australia Bank Gets Fresh Fitch AA- Call as Bad-Loan Pressure Looks Set to Ease
6 March 2026
1 min read

National Australia Bank Gets Fresh Fitch AA- Call as Bad-Loan Pressure Looks Set to Ease

SYDNEY, March 6, 2026, 17:11 AEDT

Fitch held National Australia Bank’s rating steady at AA- this Thursday. That’s significant for lenders: those ratings directly affect both the cost and accessibility of funding.

Back in February, NAB flagged in a debt update that as of Jan. 31, its outstanding term wholesale funding broke down as 60% senior debt, 17% subordinated, and 22% covered bonds — that’s debt secured by a pool of assets. The bank had tapped 45% of its covered-bond capacity. All of this keeps the ratings call in sharp focus for investors.

Timing is also a factor here. NAB is scheduled to release its half-year results on May 4. Fitch, for its part, projects the bank’s stage 3 loan ratio will edge down in FY26. These stage 3 loans—credit-impaired exposures—are a key area for monitoring stress in the portfolio.

NAB’s February quarter update helped settle nerves. For the three months ending Dec. 31, the bank posted cash earnings—its go-to profit metric—of A$2.02 billion, while net interest margin ticked up to 1.80%. Shares surged, climbing as much as 5.8% to a record high of A$47.96.

Asset quality came in stronger. NAB reported that non-performing exposures—essentially, loans under stress—dropped by 8 basis points from September, landing at 1.47% of gross loans and acceptances by the end of December. Credit impairment charge totaled A$170 million.

The results fall in line with a wider trend for the sector. In February, Commonwealth Bank delivered record first-half cash earnings. Westpac and ANZ also topped first-quarter profit forecasts—Westpac saw gains from loan and deposit growth, while ANZ’s numbers benefited from cost reductions.

Still, that could shift. All four big Australian banks, NAB among them, pushed through the Reserve Bank of Australia’s February cash rate hike—now at 3.85%—to their borrowers, and households are still feeling the impact. But another risk crept in this week. Skye Masters, NAB’s head of markets research, flagged “you see that repricing in OIS curves” and in the bond market. Overnight index swaps—OIS—remain a key tool for traders mapping out likely policy moves. Reuters

On March 3 in Singapore, Chief Executive Andrew Irvine called Australia “a very attractive destination for global capital,” highlighting the strength of its deep and well-regulated markets. For NAB, it’s now a matter of waiting to find out if that optimism translates to the upcoming results. news.nab.com.au

Michał Rogucki is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic developments. A graduate of Humboldt University of Berlin, he previously worked in investment research and market analysis before transitioning to financial journalism. He covers the trends and events that matter most to investors worldwide.

Stock Market Today

  • Neurocrine Biosciences (NBIX) Gains as Strong Earnings Forecasts Boost Stock
    June 29, 2026, 5:49 AM EDT. Neurocrine Biosciences (NBIX) has emerged as a robust biotech performer with strong earnings momentum driven by its flagship treatment INGREZZA, which treats movement disorders. Analysts have sharply raised earnings per share (EPS) estimates for NBIX across upcoming quarters and fiscal years, reflecting increased confidence in the stock. INGREZZA's sales reached $2.86 billion in 2025, up 22% year-over-year, with projected growth continuing in 2026. The company also benefits from growing physician adoption and expanding patient awareness. Rising earnings forecasts, driven by strong operational performance and a broad consensus among analysts, have elevated NBIX to a Zacks Rank #1 (Strong Buy). Investors see Neurocrine's expanding portfolio and pipeline as key to sustaining growth beyond INGREZZA's success.

Latest articles

ServiceNow (NYSE:NOW) stock: $9 billion Friday jump puts contract base back in focus

ServiceNow (NYSE:NOW) stock: $9 billion Friday jump puts contract base back in focus

29 June 2026
ServiceNow (NYSE:NOW) surged 9.85% to $98.34 Friday, adding $9.1 billion in equity value—about 72% of its $12.64 billion Q1 current remaining performance obligations—as software stocks outperformed amid rotation out of AI names; the move comes ahead of a potential near-term bookings catalyst tied to price increases and legacy tier retirements, with short interest at 5.82% of float.
Nvidia holds $47 billion-per-point sway as Nasdaq tries for bounce

Nvidia holds $47 billion-per-point sway as Nasdaq tries for bounce

29 June 2026
Nvidia’s $4.7 trillion market value means every 1% stock move shifts $47 billion, putting massive index risk in focus as AI capex spending faces fresh scrutiny from new BIS data and rising China chip competition, with premarket gains tested by funding and substitution risks.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Previous Story

Stock Market Today 03.03.2026

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Next Story

Stock Market Today 09.03.2026

Go toTop